| Zacks Company Profile for China SXT Pharmaceuticals, Inc. (SXTC : NSDQ) |
|
|
| |
| • Company Description |
| China SXT Pharmaceuticals Inc. is a pharmaceutical company. It is involved in research, development, manufacturing, marketing and sales of traditional Chinese medicine pieces including advanced TCMP as well as fine and regular TCMP products. China SXT Pharmaceuticals Inc. is based in Jiangsu, China.
Number of Employees: 75 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $1.71 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 59,165 shares |
| Shares Outstanding: 116.03 (millions) |
| Market Capitalization: $198.41 (millions) |
| Beta: 1.18 |
| 52 Week High: $5.70 |
| 52 Week Low: $0.30 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-16.18% |
-19.32% |
| 12 Week |
-20.83% |
-33.41% |
| Year To Date |
-57.93% |
-60.60% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
178 TAIDONG ROAD NORTH
-
TAIZHOU,F4 225300
CHN |
ph: 86-523-8629-8290
fax: - |
ir@sxtchina.com |
http://www.sxtchina.com |
|
|
| |
| • General Corporate Information |
Officers
Feng Zhou - Chief Executive Officer and Director
Xiaodong Pan - Chief Financial Officer
Jun Zheng - Director
Tong Liu - Director
Xiaodong Ji - Director
|
|
Peer Information
China SXT Pharmaceuticals, Inc. (GSAC)
China SXT Pharmaceuticals, Inc. (CASI)
China SXT Pharmaceuticals, Inc. (ALCD.)
China SXT Pharmaceuticals, Inc. (OMNN)
China SXT Pharmaceuticals, Inc. (CGPI.)
China SXT Pharmaceuticals, Inc. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: G2161P157
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 116.03
Most Recent Split Date: 2.00 (0.13:1)
Beta: 1.18
Market Capitalization: $198.41 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
